TherapeuticsMD Inc. – Filings and Transcripts

NASDAQ: TXMD
Share price (9/30/26): $2.03
Market cap (9/30/26): $23.5 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025 – amended

Late annual filing notification for FY 2025

ended 12/31/25 FY 2025

Prospectuses and Registrations Filter

Withdrawal of amendment

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Exempt offering of securities

Ownership Filter

Baselake Partners, LP

Baselake Partners, LP

Thompson Tommy G

Thompson Tommy G

Naughton Gail K

News Filter

Announces Second Quarter 2026 Financial Results

Announces First Quarter 2026 Financial Results

Announces Full Year 2025 Financial Results

Change in Certifying Accountant, Financial Statements or Exhibits

Shareholder Vote Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

SEC STAFF LETTER

SEC STAFF LETTER